-
Targeted CRISPRi of Fabp4 in White Adipocytes
2026-08-19
The reference study developed an adipose-targeted, nonviral CRISPR interference system to repress Fabp4 selectively in mature white adipocytes. In obese mice, this approach reduced adiposity and inflammation while improving hepatic steatosis and insulin resistance, illustrating how tissue-selective gene regulation can address systemic metabolic disease.
-
NADPH Oxidase ROS Activate L-Type Ca2+ Channels
2026-08-19
This reference study identifies L-type voltage-gated Ca2+ channels as the principal downstream effectors of NADPH oxidase-derived reactive oxygen species in saphenous arteries from early postnatal rats. Pharmacological pathway analysis separated this mechanism from Rho-kinase, PKC, and Src-kinase signaling, providing a useful framework for studying developmental regulation of vascular tone.
-
ERAD Hijacking for Membrane Protein Degradation
2026-08-18
Song and colleagues introduce ERAD-engaging chimeras (ERADECs), a targeted protein degradation platform that recruits the endoplasmic-reticulum-associated degradation machinery to remove transmembrane proteins. By using desonide to engage the ER E3 ligase SYVN1, the study achieved highly efficient PD-L1 degradation and extended the concept to mutant HTT, while also defining practical limits for translating the approach.
-
GCRV Entry: Clathrin-Mediated Endocytosis
2026-08-18
Wang et al. used pharmacological inhibition, transmission electron microscopy, and real-time quantitative PCR to investigate how genotype III grass carp reovirus enters CIK cells. Their results support a clathrin-mediated, dynamin-dependent, pH-sensitive entry route and show that latrunculin B-sensitive actin remodeling is not required under the tested conditions.
-
ML-7 Hydrochloride in Cardiovascular Research
2026-08-17
ML-7 hydrochloride is a myosin light chain kinase inhibitor with a reported Ki of 300 nM. It is used to investigate cardiac contractility, ischemia/reperfusion injury research, cytoskeletal regulation, and endothelial barrier signaling.
-
Phenytoin Workflows for Sodium Channel Research
2026-08-17
Build reproducible Phenytoin experiments across voltage-clamp and purified-enzyme platforms, from fresh stock preparation to use-dependent sodium current analysis. A complementary PON1 workflow shows how the compound can support mechanistic anti-epileptic drug research while keeping biochemical and electrophysiological conclusions appropriately separate.
-
AICAR AMPK Workflows for Metabolic Research
2026-08-16
AICAR provides a practical way to activate AMPK while connecting energy metabolism regulation with macrophage inflammation studies. This workflow-focused guide covers cell-based assay design, LPS challenge models, dose selection, solubility, validation, and troubleshooting.
-
Rottlerin (B6803): Reliable PKC Cell Assays
2026-08-15
This scenario-driven guide explains how Rottlerin (SKU B6803) can support controlled studies of PKCδ signaling, cell proliferation inhibition, and apoptosis induction. It covers solvent compatibility, dose selection, orthogonal validation, assay interpretation, and practical criteria for choosing a reliable laboratory reagent.
-
WIP1/PPM1D, p38 MAPK, and Sepsis AKI
2026-08-14
The reference study identifies WIP1/PPM1D as a suppressor of p38 MAPK-linked pyroptosis in renal tubular cells during sepsis-associated acute kidney injury. By integrating single-cell sequencing with human tissue, mouse, and HK2-cell experiments, it shows that pharmacological WIP1 inhibition intensifies inflammatory cell-death markers and kidney injury signals.
-
BET Inhibition in HPV16-Positive HNSCC
2026-08-14
The 2024 Frontiers in Oncology study shows that BET inhibition suppresses HPV16 E6 and E7 transcription in HPV-positive head and neck squamous cell carcinoma, but the magnitude of response differs across cell lines. By combining patient-data analysis, targeted transcriptional profiling, BRD4 knockdown, qRT-PCR, immunoblotting, and cell-cycle analysis, the authors connect viral oncogene suppression with c-Myc/E2F downregulation, p21 induction, G1 arrest, and apoptosis.
-
Cyclosporin A in PV Interneuron Assays
2026-08-13
Cyclosporin A provides a mechanistic control for separating calcineurin, NFAT, and mitochondrial effects from the NMDAR–Cav2.1 pathway that governs developing PV-interneuron inhibition. This workflow shows how to integrate cyclosporin for research use with paired patch clamp, calcium-channel assays, transcriptional readouts, and mitochondrial measurements without overinterpreting an indirect pharmacological effect.
-
Rottlerin PKC Inhibitor: Practical Cell Workflows
2026-08-13
Rottlerin enables controlled interrogation of PKCδ-linked cell proliferation, apoptosis, endothelial barrier regulation, and pathogen entry. This workflow-focused guide connects concentration planning, uptake assays, orthogonal apoptosis readouts, and troubleshooting to improve mechanistic confidence.
-
G-15 as a Precision Tool for GPER Signaling
2026-08-12
G-15 is a selective G protein-coupled estrogen receptor antagonist for separating GPR30 signaling from classical estrogen receptor activity. This article translates receptor pharmacology and recent mechanistic evidence into practical calcium, PI3K/Akt, and cross-validation strategies.
-
Super-Enhancer LINC01977 in Early Lung Adenocarcinoma
2026-08-12
Zhang et al. identify LINC01977 as a super-enhancer-hijacked lncRNA that promotes early-stage lung adenocarcinoma through a feed-forward canonical TGF-β/SMAD3 circuit. Their integrated epigenomic, molecular, cellular, animal, and clinical analyses connect tumor-associated macrophage signals with enhancer activation, SMAD3 function, ZEB1 regulation, and unfavorable disease-free survival.
-
Vitamin C and ROS/NF-κB Signaling in Cochlear Senescence
2026-08-11
A 2024 study used D-galactose-treated HEI-OC1 cochlear hair cells to model senescence and examined whether Vitamin C could reduce the associated oxidative and inflammatory responses. The findings link Vitamin C protection to suppression of ROS accumulation and NF-κB activation, providing a mechanistic basis for further age-related hearing loss research while remaining limited to an in vitro model.